Canada Generic Drug Market 2016 - Industry Trends, Competitive Landscape, Opportunities and Outlook for the World's 9th Biggest Market - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Canada Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook" report to their offering.

Canada Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook represents an in-depth analysis on the historical, current and future trends in the generic drug market in Canada.

This research report serves as an exceptional tool to understand the drivers, sales trends, prescription trends, market structure, competitive landscape, regulations, key players, key drugs, manufacturing and the outlook of the generic drug Market in Canada. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the Canadian generic drug market in any form.

Canada represents the world's ninth biggest market for generic drugs in terms of value. Over the past few decades, the acceptance and use of generic drugs in Canada has changed significantly. The growth of the generic drug market in Canada has been catalyzed by a number of factors.

Key Topics Covered:

1 Research Methodology and Market Definitions

2 Report Summary

3 Canada Generic Drug Market - Introduction

4 Why is the Generic Drug Market so Lucrative in Canada

5 Global Generic Drug Market

6 Canada Generic Drug Market

7 Canada Generic Drug Market- Competitive Landscape

8 Canada Generic Drug Market - Value Chain Analysis

9 Canada Generic Drug Market - Regulatory Framework

10 Canada Generic Drug Market: Key Success Factors

11 Canada Generic Drug Market: Road Blocks

12 Requirements for Setting Up a Generic Drug Manufacturing Plant

13 Canada Generic Drug Market - Key Company Profiles

13.1 Teva Pharmaceutical Ltd.

13.2 Apotex Inc.

13.3 Sandoz Canada

13.4 Actavis

13.5 Mylan

13.6 Pharmascience Inc.

13.7 Taro Pharmaceuticals

13.8 Novartis

13.9 Ranbaxy Pharmaceuticals Canada

13.10 Hospira

For more information visit http://www.researchandmarkets.com/research/jj8d9v/canada_generic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Generic Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Generic Drugs